Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human”

1,164 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,164
Index total 30,257
Page 37 / 49

Quick answer

This filtered view shows 1,164 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,164 results for “The United States of America, as represented by the Secretary, Department of Health and Human” · 30,257 patents in full index Clear search

  1. US 9173898

    Methods of treating giardiasis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  2. US 9175038

    Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  3. US 9175057

    Immunogenic peptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  4. US 9175062

    Human soluble receptor for advanced glycation end products (sRAGE), methods of preparing human sRAGE, and treatment methods using sRAGE

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  5. US 9175070

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  6. US 9173931

    Process for preparing polysaccharide-protein conjugate vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  7. US 9169297

    Subgenomic replicons of the flavivirus dengue

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  8. US 9169296

    Expression and assembly of human group C rotavirus-like particles and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  9. US 9168291

    β-mannosylceramide and stimulation of NKT cell anti-tumor immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  10. US 9169182

    Chrysophaentin analogs that inhibit FtsZ protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  11. US 9168297

    Regulation of skin pigmentation by neuregulin-1 (NRG-1)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  12. US 9168266

    Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  13. US 9163258

    Method for the treatment of obesity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  14. US 9150644

    Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  15. US 9150926

    Diagnosis and treatment of adrenocortical tumors using human microRNA-483

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  16. US 9151762

    Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  17. US 9144604

    Vaccine for Shigella

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  18. US 9139595

    Biologically active macrolides, compositions, and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  19. US 9140687

    Renal cell carcinoma biomarkers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  20. US 9133480

    Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  21. US 9133478

    Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  22. US 9127056

    Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  23. US 9128080

    Modified T cell receptors and related materials and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  24. US 9114102

    Method of inhibiting ABCG2 and related treatments

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.